Tethered Interleukin-15 and Interleukin-21
Copyright © Targeted News Service 2024
2024-12-03
ALEXANDRIA, Virginia, Dec. 3 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, Bethesda, Maryland has been assigned a patent (No. US 12157762 B2, initially filed May 2, 2023) developed by Christian S. Hinrichs, Princeton, New Jersey, and Benjamin Y. Jin, Bethesda, Maryland, for "Tethered interleukin-15 and interleukin-21." . . .